Osteoprotegerin (OPG) is a glycoprotein that plays a critical role in bone metabolism by inhibiting osteoclast differentiation and activity, thus preventing excessive bone resorption. It acts as a decoy receptor for the receptor activator of nuclear factor kappa-B ligand (RANKL), blocking its interaction with RANK on osteoclasts and their precursors.